Recombinant somatropin (Cangene)

重组生长激素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant somatropin (Cangene)
Drug Alias NameAccretropinrhGH (Cangene)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsTurner SyndromeHypopituitarism
Global Approved IndicationsTurner SyndromeHypopituitarism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2008/01/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesApotexEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent
Active IndicationsN/A
Inactive IndicationsTurner SyndromeHypopituitarism

Other Information

ATC CodeH01AC01
Related LinksWikipediaDrugBankKEGG